BETA-AMYLOID PROTEIN - ANVISA Registration 10230730199

Access comprehensive regulatory information for BETA-AMYLOID PROTEIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10230730199 and manufactured by NL COMÉRCIO EXTERIOR LTDA. The registration is held by NL COMÉRCIO EXTERIOR LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including FUJIREBIO EUROPE N.V., EUROIMMUN AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10230730199
Registration Details
ANVISA Registration Number: 10230730199
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Kit de Teste para Detecção de ß-Amilóide 1-42 (Aß1-42)
Risk Class II

Registration Details

10230730199

25351004861202574

52541273000147

Company Information

Brazil
PT: BRASIL

Dates and Status

Mar 05, 2025

VIGENTE

09/18/2025 19:00:01